
Charlie Sheen claims experimental HIV drug was kept off market because 'it's a threat' to industry
Fox News
Charlie Sheen discusses an experimental HIV drug called PRO 140 that showed promising results but never reached the market during a podcast appearance.
Christina Dugan Ramirez is an entertainment writer for Fox News Digital.
"There was one that was really good that I was hoping would come to market one day, and it never did," said Sheen, who revealed his HIV status in 2015. "That was a thing called PRO 140. It was an MAB [monoclonal antibody] that had much … just quicker and I think more stable results with no side effects than the traditional."
More Related News













